Friday 31 March 2017

In-Depth Research on Global Prostate Biopsy Market 2017-2021

Report Global Prostate Biopsy Market 2017-2021 is a new market research publication announced by Reportstack. 
Report Outline: Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments.
For detailed report with TOC, please click here ​Global Prostate Biopsy Market 2017-2021
Market Growth: The global prostate biopsy market to grow at a CAGR of 12.66% during the period 2017-2021.
Key vendors • C.R. Bard 
• Cook Medical
• Endomed Systems
• SOMATEX Medical Technologies
• Biomedical
Other prominent vendors • Amecath 
• AprioMed 
• Argon Medical Devices
• Biopsybell 
• Boston Scientific
• Exosome Diagnostics
• MDNA Life Sciences
• MDxHealth
• Möller Medical
• Pathway Genomics
• Predicine
• Sterylab
• TSK Laboratory Europe
• UroMed
• Urotech
Regions Covered:
• Americas
• EMEA
• APAC
Companies Mentioned
C.R. Bard, Cook Medical, Endomed Systems, SOMATEX Medical Technologies, Biomedical, Amecath, AprioMed, Argon Medical Devices, Biopsybell, Boston Scientific, Exosome Diagnostics, MDNA Life Sciences, MDxHealth, Möller Medical, Pathway Genomics, Predicine, Sterylab, TSK Laboratory Europe, UroMed, and Urotech.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

No comments:

Post a Comment